Fiscal year 2023 general medical research and development command and joint program committees support
Ended Awarded Last action
- Contract number
- HT942523F0289
- Awardee
-
Leidos, Inc. UEI QLNMVC12KWY3 Part of Leidos Holdings, Inc.
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $182,607
Award facts
- Opportunity
-
- Meeting, Programmatic, and Administrative Support Services Pre-Solicitation · W81XWH22R0025 · Posted Aug 16, 2021
- Contract value 71% obligated
- $255,432.22 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 541990 All Other Professional, Scientific, and Technical Services
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Chantilly, VA 20151, USA
- Legislative mandates
-
- Walsh-Healey Public Contracts Act FAR subpart 22.6
- Service Contract Act FAR subpart 22.10
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$136 | |
| Funding Only Action | $12,711 | |
| Funding Only Action | -$28,492 | |
| Supplemental Agreement for work within scope | -$44,740 | |
| Supplemental Agreement for work within scope | $7,209 | |
| Original award | $236,055 |
About this award
The Defense Health Agency awarded a delivery order valued at $255,432.22 to Leidos, Inc. (operating as SAIC under its Leidos Services Operating Segment) on August 26, 2023, for Fiscal Year 2023 General Medical Research and Development Command and Joint Program Committees Support. This cost-plus-fixed-fee contract, which completed on August 25, 2024, supports the U.S. Army Medical Research and Development Command and associated joint program committee activities. The work was performed in Chantilly, Virginia. No small business set-aside designation was applied to this award, reflecting the competitive nature of the procurement.
This delivery order represents Leidos' continued engagement in medical research support services for the Defense Health Agency, aligning with the company's extensive portfolio in federal health research initiatives. As a mature global technology and engineering solutions provider with significant experience supporting defense and health-related missions, Leidos has demonstrated sustained capability in delivering research program support across multiple scientific domains. The limited contract ceiling suggests this delivery order may represent a specific task or phase within a larger indefinite delivery contract vehicle, consistent with Leidos' established relationship with the Defense Health Agency in medical research program administration.
Quick answers
Who was awarded contract HT942523F0289?
HT942523F0289 was awarded to Leidos, Inc. by Defense Health Agency (Department of Defense) on August 26, 2023.
How much is contract HT942523F0289 worth?
The government has obligated $182,607 on HT942523F0289. Its current value, with exercised options, is $255,432.
Is contract HT942523F0289 an order under another contract?
Yes. HT942523F0289 is a delivery order under HT942523D0002, an indefinite delivery contract.
Was contract HT942523F0289 competed?
The extent of competition for HT942523F0289 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award